The U.S. Government’s Department of Justice has recently prosecuted conduct involving the marketing and distribution of Melanotan I, Melanotan II, Growth Hormone Releasing Hormone (“CJC-1295”), Growth Hormone Releasing Peptide-6 (“GHRP-6”), GHRP-2, GHRH-RP, Myostatin Propeptide, Mechano Growth Factor (“MGF”) and other peptide chemicals for “Research Purposes Only.”  Collins, McDonald & Gann partner and SteroidLaw.com founder Rick…